This video from the Irish Lung Fibrosis Association is all about Noreen. Noreen was diagnosed with idiopathic pulmonary fibrosis (IPF) in June 2015. Find out more about idiopathic pulmonary fibrosis in a nutshell. Noreen talks about the shock of receiving her diagnosis and worrying about how she…
Idiopathic Pulmonary Fibrosis Stories: Noreen
Veracyte has announced the launch of its non-invasive test to improve the diagnosis of interstitial lung diseases, including  idiopathic pulmonary fibrosis (IPF). The soon-to-be commercially available test, Envisia Genomic Classifier, is reported to offer a faster and more accurate diagnosis than is currently available without the need for a lung biopsy. Data…
Nutrition for Pulmonary Fibrosis: Sweet Potatoes
Nutritious Sweet Potatoes Do you enjoy sweet potatoes? Did you know they’re a super food that contain many nutritional benefits? The World’s Healthiest Foods, list numerous benefits of incorporating sweet potatoes into your diet. Some of these health benefits include increasing your antioxidant intake, consuming more anti-inflammatory…
What Is an HRCT Scan?
This Boehringer Ingelheim Idiopathic Pulmonary Fibrosis video explains high-resolution computerized tomography (HRCT) scans. While there is no known cause for idiopathic pulmonary fibrosis, there are some aspects which could be to blame. Find out more. This animated film explains why patients with pulmonary fibrosis would need an HRCT…
Patients with idiopathic pulmonary fibrosis (IPF) have a high risk of developing other health conditions, according to results of a study presented at the annual meeting of the American College of Chest Physicians (CHEST 2016), held in Los Angeles Oct. 22-26. The results were presented under the title “Longitudinal…
Sometimes it is hard to keep going when you have pulmonary fibrosis The basics of living life and traveling are now such a challenge for me … like breathing, walking, being tired, having to bring oxygen and needing help. I recently attended a Writer’s…
The effectiveness of long-term treatment with the anti fibrotic drug Esbriet (pirfenidone) for more than 3 years does not depend on the forced vital capacity (FVC) at baseline in patients with idiopathic pulmonary fibrosis (IPF), according to a clinical trial called RECAP (NCT00662038).
6 Non-Pharmacological Pulmonary Fibrosis Tips
According to PulmonaryFibrosis.org, there are several types of treatment options to help you with your pulmonary fibrosis. In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. 1. Do not smoke! If you’ve been diagnosed with pulmonary fibrosis or any other lung disease, smoking is…
Esbriet (pirfenidone) can be used as a long-term therapy in idiopathic pulmonary fibrosis (IPF) patients with more severe loss of lung function, according to results presented at the American College of Chest Physicians (CHEST 2016), held in Los Angeles from Oct. 22–26. The findings were described in the oral presentation, “…
The State of Idiopathic Pulmonary Fibrosis Research
In this University of Exeter video, Dr. Chris Scotton talks about his research in idiopathic pulmonary fibrosis in order to better understand the development of the disease, and to try to develop new model systems for drug testing. Discover why pulmonary fibrosis is so…
Your PF Community
Recommended Posts
- New generic of Ofev for IPF approved by FDA, slated for ‘immediate’ launch
- Working to bring the PF and broader ILD communities together
- 4 navigation tools that guided me on my journey with IPF
- How supplemental oxygen helps my husband stay active
- Lab study IDs OG treatment for further testing, potential use in IPF
